Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Josephine T Tauer"'
Publikováno v:
JBMR Plus, Vol 3, Iss 8, Pp n/a-n/a (2019)
ABSTRACT Osteogenesis imperfecta (OI) is a monogenic bone fragility disorder that usually is caused by mutations in one of the two genes coding for collagen type I alpha chains, COL1A1 or COL1A2. Mutations in at least 18 other genes can also lead to
Externí odkaz:
https://doaj.org/article/88b665a9a3d547549f54dfd4ec05c5b9
Autor:
Josephine T Tauer, Lorenz C Hofbauer, Roland Jung, Sebastian Gerdes, Ingmar Glauche, Reinhold G Erben, Meinolf Suttorp
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0131192 (2015)
The tyrosine kinase (TK) inhibitor imatinib provides a highly effective therapy for chronic myeloid leukemia (CML) via inhibition of the oncogenic TK BCR-ABL1. However, off-target TKs like platelet-derived growth factor receptors (PDGF-R) and colony-
Externí odkaz:
https://doaj.org/article/633bde184ccf43b7b987013247cb3778
Development of a facile method to compute collagen network pathological anisotropy using AFM imaging
Autor:
Emilie Khattignavong, Mehrnoosh Neshatian, Mina Vaez, Amaury Guillermin, Josephine T. Tauer, Marianne Odlyha, Nimish Mittal, Svetlana V. Komarova, Hassan Zahouani, Laurent Bozec
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Type I collagen, a fundamental extracellular matrix (ECM) component, is pivotal in maintaining tissue integrity and strength. It is also the most prevalent fibrous biopolymer within the ECM, ubiquitous in mammalian organisms. This structural
Externí odkaz:
https://doaj.org/article/9afa8d0790d9407fbf35a5460f0e12b5
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Osteogenesis imperfecta (OI) is a rare bone disease that is associated with fractures and low bone mass. Sclerostin inhibition is being evaluated as a potential approach to increase bone mass in OI. We had previously found that in Col1a1 Jrt
Externí odkaz:
https://doaj.org/article/159067d733a54de487fe954a2d222d85
Publikováno v:
Hämostaseologie.
The tyrosine kinase inhibitors (TKIs) imatinib, dasatinib, bosutinib, and nilotinib are established for first-line treatment of chronic myeloid leukemia (CML) but may cause side effects such as bleeding and thrombotic complications. We investigated t
Autor:
Rick Proschmann, Christoph Baldow, Tino Rothe, Meinolf Suttorp, Christian Thiede, Josephine T. Tauer, Martin C. Müller, Andreas Hochhaus, Ingo Roeder, Ingmar Glauche
Publikováno v:
Haematologica, Vol 102, Iss 2 (2017)
Externí odkaz:
https://doaj.org/article/2237626172cd400ebc0992aac09a5954
Autor:
Josephine T. Tauer, Hadil Al-Jallad, Mayumi Umebayashi, Dena Bakhsh, Damian Rauch, Simon D. Tran, Frank Rauch, Reggie Hamdy
Publikováno v:
Scientific reports. 12(1)
Pediatric patients with Osteogenesis Imperfecta (OI), a heritable connective tissue disorder, frequently suffer from long bone deformations. Surgical correction often results in bone non-unions, necessitating revision surgery with autogenous bone gra
Publikováno v:
Data in brief. 41
Male and female mice with a dominant severe bone fragility disorder, osteogenesis imperfecta, and their wild-type littermates (FVB background) were challenged with a long-term (26 weeks) high-fat diet to evaluate the development of obesity and glucos
Publikováno v:
Bone Reports, Vol 14, Iss, Pp 100864-(2021)
Autor:
Mariya Stavnichuk, Mélanie Welman, Svetlana V. Komarova, Yotis A. Senis, Alexandra Mazharian, Marie Lordkipanidzé, Zoltan Nagy, Josephine T. Tauer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84a68b35b5bf808238db4160b32c85a5
https://doi.org/10.1002/jbmr.4245/v2/response1
https://doi.org/10.1002/jbmr.4245/v2/response1